基本信息
views: 155
Career Trajectory
Bio
A major focus of my work has been the endogenous cannabinoid system, with particular attention on inflammation and pain. In this context, three of my most highly-cited publications investigated vasoactivity of anandamide (the first identified endocannabinoid), neuroprotection via cannabinoid activation of PPARα and the regulation of dopaminergic neurotransmission in the striatum. My central area of research concerns the pharmacology and biochemistry of G protein-coupled receptors (in particular, cannabinoid, adenosine and glutamate) in the CNS and peripheral tissues. I am interested in how activation of one of these classes of receptor leads to modification of the response to other receptor classes (cross-talk), as well as how different ligands can provoke different signalling profiles at the same receptor (agonist bias).
An additional focus of my research has been an investigation of enzymes (particularly those involved in turnover of endocannabinoids, hydrogen sulphide and cyclic nucleotides), as convergence points for signalling cross-talk, as well as quantifying enzyme activities ex vivo, for example, in pathological conditions or following drug exposure. I also investigate key enzymes as targets for drug discovery, generating high-throughput assays in vitro. A third area of research is the role of mitochondria in cell survival and/or toxicity following drug exposure or under substrate-limited conditions.
An additional focus of my research has been an investigation of enzymes (particularly those involved in turnover of endocannabinoids, hydrogen sulphide and cyclic nucleotides), as convergence points for signalling cross-talk, as well as quantifying enzyme activities ex vivo, for example, in pathological conditions or following drug exposure. I also investigate key enzymes as targets for drug discovery, generating high-throughput assays in vitro. A third area of research is the role of mitochondria in cell survival and/or toxicity following drug exposure or under substrate-limited conditions.
Research Interests
Papers共 799 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BRITISH JOURNAL OF PHARMACOLOGYno. 11 (2024): 1553-1575
JCI insightno. 6 (2024)
Clinical journal of the American Society of Nephrology : CJASNno. 7 (2024): 887-897
Shi-Ting Wu, Yu Feng,Renhua Song, Yanmiao Qi,Lin Li,Dongbo Lu,Yixuan Wang,Wenrun Wu,Angela Morgan,Xiaohong Wang,Yin Xia,Renjing Liu,
Journal of the American Society of Nephrology : JASNno. 5 (2024): 533-548
British Journal of Pharmacologyno. S2 (2023): S374-S469
crossref(2023)
British Journal of Pharmacologyno. S2 (2023): S23-S144
Nucleic acids researchno. D1 (2023): D1438-D1449
Load More
Author Statistics
#Papers: 777
#Citation: 38301
H-Index: 85
G-Index: 186
Sociability: 8
Diversity: 1
Activity: 5
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn